Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31Other information technology service activitiestrue2022-12-13false1false 14539160 2022-12-12 14539160 2022-12-13 2023-12-31 14539160 2022-01-01 2022-12-12 14539160 2023-12-31 14539160 c:Director1 2022-12-13 2023-12-31 14539160 d:CurrentFinancialInstruments 2023-12-31 14539160 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 14539160 d:ShareCapital 2023-12-31 14539160 d:RetainedEarningsAccumulatedLosses 2023-12-31 14539160 c:FRS102 2022-12-13 2023-12-31 14539160 c:Audited 2022-12-13 2023-12-31 14539160 c:FullAccounts 2022-12-13 2023-12-31 14539160 c:PrivateLimitedCompanyLtd 2022-12-13 2023-12-31 14539160 c:SmallCompaniesRegimeForAccounts 2022-12-13 2023-12-31 14539160 e:PoundSterling 2022-12-13 2023-12-31 iso4217:GBP xbrli:pure

Registered number: 14539160









MYSTEN LABS UK LTD









FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 DECEMBER 2023

 
MYSTEN LABS UK LTD
REGISTERED NUMBER: 14539160

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
Note
£

  

Current assets
  

Cash at bank and in hand
 4 
152

  
152

Creditors: amounts falling due within one year
 5 
(7,833)

Net current (liabilities)/assets
  
 
 
(7,681)

Total assets less current liabilities
  
(7,681)

  

Net (liabilities)/assets
  
(7,681)


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
(7,781)

  
(7,681)


The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 September 2024.




Abiodun Adeniyi
Director

The notes on pages 2 to 3 form part of these financial statements.
Page 1

 
MYSTEN LABS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Mysten Labs UK Ltd is a private company, limited by shares, registered in England and Wales, registration number 14539160.
The registered office is 55 Loudoun Road St John's Wood, London, United Kingdom, NW8 0DL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including the director, during the period was as follows:


        2023
            No.






Directors
1

Page 2

 
MYSTEN LABS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

4.


Cash and cash equivalents

2023
£

Cash at bank and in hand
152

152



5.


Creditors: Amounts falling due within one year

2023
£

Amounts owed to group undertakings
293

Accruals and deferred income
7,540

7,833



6.


Related party transactions

Mysten Labs Inc owns 100% of the share capital of Mystens Labs UK Ltd. As at the period ended 31 December 2023, the intercompany balance between Mysten Labs Inc and Mysten Labs UK Ltd was £293.07.


7.


Auditors' information

The auditors' report on the financial statements for the period ended 31 December 2023 was unqualified.

The audit report was signed on 10 September 2024 by Nicholas R Newman (Senior Statutory Auditor) on behalf of Harris & Trotter LLP.

 
Page 3